language_icon
EN
HI

Mukka Proteins Share price

MUKKA

22.38

0.12 (0.54%)
NSE
BSE
Last updated on 2 Jun, 2026 | 15:31 IST
Today's High

22.67

Today's Low

21.96

52 Week Low

18.27

52 Week High

32.80

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Mukka Proteins Chart

Mukka Proteins Share Key Metrics

Volume
3.03 L
Market Cap
671.40 CR
LTQ@LTP
66@22.38
ATP
22.28
Var Margin
17.8 %
Circuit Range
17.81-26.71
Delivery %
74.04 %
Value
67.53 L
ASM/GSM
No
Market Lot
1

Summary

Mukka Proteins share price is ₹22.38 as of 3 Jun, 2026. The stock Mukka Proteins intraday movement has stayed between ₹21.96 and ₹22.67, while on a 52-week basis,Mukka Proteins price 52 week high is ₹32.80 & its 52 week low is ₹18.27.
In terms of trading activity, Mukka Proteins has recorded a volume of 303108 shares, The Mukka Proteins has a market cap of ₹300000000 CR. The stock’s Average Traded Price (ATP) stands at ₹22.28, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 66 @ ₹22.38.
Mukka Proteins operates within a circuit range of ₹17.81 – ₹26.71, with a Value of ₹67.53 L. The Delivery Percentage for the day is 74.04%. Additionally, Mukka Proteins currently falls under the No framework, and trades with a market lot size of 1.

Mukka Proteins Fundamentals

View More
P/E Ratio

12.81

P/B Ratio

1.34

Div. Yield

0

Sector P/E

14

Sector P/B

2.76

Sec. Div. Yield

0.55

Mukka Proteins Resistance and Support

Pivot 22.6

Resistance

First Resistance

23.04

Second Resistance

23.83

Third Resistance

24.27

Support

First Support

21.81

Second Support

21.37

Third Support

20.58

Mukka Proteins Shareholding Pattern

View More
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

73.33%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

1.7%

Domestic Institutional Investors

0%

Retail

24.97%

Others

0%

Total Promoters
MAR '26
73.33%

Mukka Proteins Corporate Actions

DateAgenda
2026-05-15Audited Results & Raising of funds
2026-02-12Quarterly Results
2026-02-10Quarterly Results
2025-11-12Quarterly Results
2025-08-13Quarterly Results & Others
2025-05-15Audited Results
2025-02-14Quarterly Results & Others

Mukka Proteins News

Mukka Proteins Limited

Mukka Proteins' credit rating for long-term bank facilities has been downgraded by CARE Ratings to CARE BBB-; Negative. This downgrade is attributed to the company's elongated working capital cycle and high inventory levels, impacting its liquidity buffer.
May 26 2026 17:27:26

Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Credit Rating

CARE Ratings has downgraded Mukka Proteins' credit ratings for its long-term bank facilities to BBB- Negative and short-term debt to A3. This action primarily stems from a continued elongation of the company's working capital cycle and deteriorated debt coverage indicators.
May 26 2026 17:26:18

Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Mukka Proteins reported strong FY26 performance, with revenue growing 44% YoY to Rs.1,449.5 crore and PAT increasing 18.7% YoY to Rs.57.1 crore. The company is also undertaking strategic expansions in Oman and Sri Lanka and secured a waste management contract.
May 16 2026 19:53:29

Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Acquisition

Mukka Proteins Ltd approved the incorporation of 'MPL FC HRC JV', a new partnership firm. This venture, with a 51% capital contribution, will focus on animal waste treatment and disposal, executing a work order from the company's Joint Venture.
May 15 2026 17:40:38

Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Acquisition

Mukka Proteins Ltd's board approved the incorporation of Lanka Bio Proteins Private Limited in Sri Lanka. The company will invest Rs.2.5 crore for a 49% stake to expand its international marine products operations, with completion by December 2026.
May 15 2026 17:38:43

Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Raising of Funds

Mukka Proteins' Board approved raising up to Rs. 50 crore through secured, rated, listed Non-Convertible Debentures via private placement. These debentures will carry a 12% annual coupon and have a 15-month tenure.
May 15 2026 17:29:36

Mukka Proteins Ltd - 544135 - Board Meeting Outcome for Intimation Of The Outcome Of Board Meeting Held On 15Th May 2026.

Mukka Proteins' board approved Q4 FY26 cons. financial results, reporting ₹367.92 cr revenue and ₹20.62 cr net profit. Additionally, they approved raising ₹75 cr through debentures, a ₹2.55 lakh investment for a 51% stake in a new JV, and a ₹2.5 cr investment for a 49% stake in a Sri Lankan entity to expand operations.
May 15 2026 17:02:05

Mukka Proteins Ltd - 544135 - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Quarter And Year Ended 31St March 2026 And Consider Raising Of Funds By Way Of Issuance Of NCD''s.

Mukka Proteins' Board of Directors is scheduled to meet on May 15, 2026. The agenda includes considering the audited financial results for Q4 FY26 and proposals for raising funds totaling up to Rs. 75 crore through non-convertible debentures via private placement.
May 12 2026 17:06:12
Read More

Mukka Proteins Management

NamePosition
Mehaboobsab Mahmadgous ChalyalCompany Secretary & Compliance Officer
Karkala Shankar Balachandra RaoChairman
View More

Mukka Proteins FAQs

The Buying Price of Mukka Proteins share is 22.38 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Mukka Proteins stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Mukka Proteins, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Mukka Proteins shares is 12.81. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Mukka Proteins shares is 1.34. Useful to assess the stock's value relative to its book value.

To assess Mukka Proteins’s valuation compare Sector P/E, P/B which are 14 & 2.76 with sector averages, along with growth rates and financial metrics.

The Market Cap of Mukka Proteins is 671.40 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Mukka Proteins share price is 32.80 & 18.27. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Mukka Proteins belongs to the FMCG sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost